Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Immuneering Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +3 vs. Q3 2022
- Shares held
- 11.7M
- −282.1K (−2.3%) vs. Q3 2022
- Total value
- $56.9M
- −$114.8M (−66.9%) vs. Q3 2022
- New holders
- 7
- 10 more added
- Sold out
- 4
- 11 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 3,619,560 | $17.6M | 0.00% | −43,932−1.2% | Reduced |
| Cormorant Asset Management, LP | 2,286,181 | $11.1M | 0.75% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,141,497 | $10.4M | 0.01% | −43,412−2.0% | Reduced |
| BlackRock Inc. | 1,348,384 | $6.54M | 0.00% | −75,650−5.3% | Reduced |
| Vanguard Group Inc | 837,679 | $4.06M | 0.00% | +19,190+2.3% | Added |
| T. Rowe Price Investment Management, Inc. | 458,233 | $2.22M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 169,219 | $820.0K | 0.00% | −372−0.2% | Reduced |
| FMR LLC | 153,063 | $742.4K | 0.00% | −69,951−31.4% | Reduced |
| TD Asset Management Inc | 146,714 | $711.6K | 0.00% | −947−0.6% | Reduced |
| Manufacturers Life Insurance Company, The | 82,547 | $409.4K | 0.00% | +110.0% | Added |
| Adage Capital Partners GP, L.L.C. | 75,000 | $363.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 54,035 | $262.1K | 0.00% | +24,900+85.5% | Added |
| CI Private Wealth, LLC | 47,419 | $230.0K | 0.00% | +47,419 | New |
| Morgan Stanley | 45,416 | $220.3K | 0.00% | +33,667+286.6% | Added |
| Susquehanna International Group, LLP | 45,000 | $218.3K | 0.00% | +45,000 | New |
| Bridgeway Capital Management, LLC | 34,949 | $169.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 34,660 | $168.1K | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 32,603 | $158.1K | 0.05% | +32,603 | New |
| Gsa Capital Partners LLP | 23,371 | $113.0K | 0.01% | −9,739−29.4% | Reduced |
| Millennium Management LLC | 19,670 | $95.0K | 0.00% | +9,406+91.6% | Added |
| Qube Research & Technologies Ltd | 19,394 | $94.1K | 0.00% | +6,079+45.7% | Added |
| Man Group plc | 18,368 | $89.1K | 0.00% | +18,368 | New |
| Goldman Sachs Group Inc | 10,277 | $49.8K | 0.00% | −1,551−13.1% | Reduced |
| Barclays PLC | 6,758 | $32.8K | 0.00% | +2,168+47.2% | Added |
| Tower Research Capital LLC (TRC) | 6,376 | $31.0K | 0.00% | +3,659+134.7% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,148 | $20.1K | 0.00% | +4,148 | New |
| JPMorgan Chase & Co | 960 | $5.00K | 0.00% | −183−16.0% | Reduced |
| Bank of America Corp | 531 | $2.58K | 0.00% | +493+1,297.4% | Added |
| Citigroup Inc | 403 | $1.96K | 0.00% | −3,806−90.4% | Reduced |
| China Universal Asset Management Co., Ltd. | 268 | $1.30K | 0.00% | +21+8.5% | Added |
| Wells Fargo & Company | 124 | $601 | 0.00% | −997−88.9% | Reduced |
| Credit Suisse AG | 58 | $281 | 0.00% | +58 | New |
| Daiwa Securities Group Inc. | 76 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 81 | $0 | 0.00% | +81 | New |
| Buckingham Strategic Wealth, LLC | 0 | $0 | 0.00% | −200,200−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −67,160−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −11,366−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Kore Private Wealth LLC | – | – | – | – | Not filed |